Literature DB >> 31540830

Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.

Brett A Johnson1, Sandy Kim2, Ryan L Steinberg1, Alberto Diaz de Leon3, Ivan Pedrosa4, Jeffrey A Cadeddu5.   

Abstract

INTRODUCTION: Detection of small renal masses (SRM) is increasing with the use of cross-sectional imaging, although many incidental lesions have negligible metastatic potential. A method to identify this subtype would aid in risk stratification. A previously reported clear cell likelihood score (ccLS; 1-very unlikely, 2-unlikely, 3-equivocal, 4-likely, and 5-very likely), based on retrospective review of multiparametric magnetic resonance imaging (mpMRI), predicted the likelihood of encountering clear cell renal cell carcinoma (ccRCC) at surgery. Here, we assess the performance of ccLS prospectively assigned for prediction of ccRCC.
METHODS: Patients with a known renal mass who underwent mpMRI at a single institution between June 2016 and April 2018 were prospectively assigned a ccLS as part of the clinical MRI report. These patients were retrospectively reviewed, and those with a cT1a lesion and available pathological tissue diagnosis (diagnostic biopsy or extirpative surgery) were selected for analysis.
RESULTS: In total, 57 patients (mean age 61.7 ± 14.9 years) with 63 cT1a renal masses were identified. Mean tumor size was 2.7 ± 0.7 cm. Defining ccLS 4-5 lesions as positive demonstrated an overall accuracy of 84%, sensitivity of 89%, specificity of 79%, positive predictive value of 84%, and negative predictive value of 86%. A ccLS of 1-2 demonstrates an 86% accuracy and 100% sensitivity/positive predictive value of identifying non-ccRCC histology.
CONCLUSIONS: Utilizing prospectively assigned ccLS, we confirm that mpMRI can reasonably identify ccRCC histology in cT1a renal masses. Standardization of imaging protocols and reporting criteria such as the ccLS can be used to aid in the diagnosis and management of small renal masses.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clear Cell Likelihood Score; Multiparametric Magnetic; Partial Nephrectomy; Renal Cell Carcinoma; Renal Mass Biopsy; Resonance Imaging; Small Renal Mass

Year:  2019        PMID: 31540830      PMCID: PMC6934987          DOI: 10.1016/j.urolonc.2019.07.023

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  27 in total

1.  MR classification of renal masses with pathologic correlation.

Authors:  Ivan Pedrosa; Mary T Chou; Long Ngo; Ronaldo H Baroni; Elizabeth M Genega; Laura Galaburda; William C DeWolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2007-09-26       Impact factor: 5.315

2.  Renal Mass Biopsy: Always, Sometimes, or Never?

Authors:  Alexander Kutikov; Marc C Smaldone; Robert G Uzzo; Miki Haifler; Gennady Bratslavsky; Bradley C Leibovich
Journal:  Eur Urol       Date:  2016-04-13       Impact factor: 20.096

3.  Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management.

Authors:  B J Wood; M A Khan; F McGovern; M Harisinghani; P F Hahn; P R Mueller
Journal:  J Urol       Date:  1999-05       Impact factor: 7.450

Review 4.  Increased incidence of serendipitously discovered renal cell carcinoma.

Authors:  M Jayson; H Sanders
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

Review 5.  Imaging of Solid Renal Masses.

Authors:  Fernando U Kay; Ivan Pedrosa
Journal:  Radiol Clin North Am       Date:  2016-12-12       Impact factor: 2.303

6.  Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses.

Authors:  Noah E Canvasser; Fernando U Kay; Yin Xi; Daniella F Pinho; Daniel Costa; Alberto Diaz de Leon; Gaurav Khatri; John R Leyendecker; Takeshi Yokoo; Aaron Lay; Nicholas Kavoussi; Ersin Koseoglu; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  J Urol       Date:  2017-04-28       Impact factor: 7.450

7.  Diagnostic Yield and Complication Rate in Percutaneous Needle Biopsy of Renal Hilar Masses With Comparison With Renal Cortical Mass Biopsies in a Cohort of 195 Patients.

Authors:  Steven Cooper; Trevor A Flood; Mohammed El Khodary; Wael M Shabana; Demetri Papadatos; Luke T Lavallee; Nicola Schieda
Journal:  AJR Am J Roentgenol       Date:  2019-01-15       Impact factor: 3.959

8.  Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses.

Authors:  Yann Neuzillet; Eric Lechevallier; Marc Andre; Laurent Daniel; Christian Coulange
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

Review 9.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Authors:  Holger Moch; Antonio L Cubilla; Peter A Humphrey; Victor E Reuter; Thomas M Ulbright
Journal:  Eur Urol       Date:  2016-02-28       Impact factor: 20.096

10.  Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.

Authors:  Maryellen R M Sun; Long Ngo; Elizabeth M Genega; Michael B Atkins; Myra E Finn; Neil M Rofsky; Ivan Pedrosa
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

View more
  5 in total

1.  Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.

Authors:  Joseph R Grajo; Nikhil V Batra; Shahab Bozorgmehri; Laura L Magnelli; Jonathan Pavlinec; Padraic O'Malley; Li-Ming Su; Paul L Crispen
Journal:  Abdom Radiol (NY)       Date:  2021-03-04

2.  Canadian Urological Association guideline: Management of small renal masses - Full-text.

Authors:  Patrick O Richard; Philippe D Violette; Bimal Bhindi; Rodney H Breau; Wassim Kassouf; Luke T Lavallée; Michael Jewett; John R Kachura; Anil Kapoor; Maxine Noel-Lamy; Michael Ordon; Stephen E Pautler; Frédéric Pouliot; Alan I So; Ricardo A Rendon; Simon Tanguay; Christine Collins; Maryam Kandi; Bobby Shayegan; Andrew Weller; Antonio Finelli; Andrea Kokorovic; Jay Nayak
Journal:  Can Urol Assoc J       Date:  2022-02       Impact factor: 1.862

Review 3.  How We Do It: Managing the Indeterminate Renal Mass with the MRI Clear Cell Likelihood Score.

Authors:  Ivan Pedrosa; Jeffrey A Cadeddu
Journal:  Radiology       Date:  2021-12-14       Impact factor: 29.146

4.  Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging.

Authors:  Ryan L Steinberg; Robert G Rasmussen; Brett A Johnson; Rashed Ghandour; Alberto Diaz De Leon; Yin Xi; Takeshi Yokoo; Sandy Kim; Payal Kapur; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  Eur Radiol       Date:  2020-08-08       Impact factor: 5.315

5.  Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.

Authors:  Robert G Rasmussen; Yin Xi; R Carson Sibley; Christopher J Lee; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  AJR Am J Roentgenol       Date:  2021-07-21       Impact factor: 6.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.